Evidence map›Paper›PMID 33920265›Full record

ArticleMicroorganisms2021

Genomic Insights into a Colistin-Resistant Uropathogenic

Azza S Zakaria, Eva A Edward, Nelly M Mohamed

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Characterization of anAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades ofAntibiotics (Basel, Switzerland) · 2024
    Article
  16. A review of colistin-resistantArchives of Razi Institute · 2024
    Review
  17. A review of the mechanisms that confer antibiotic resistance in pathotypes ofFrontiers in cellular and infection microbiology · 2024
    Review
  18. Article
  19. Carriage and within-host diversity ofEmerging microbes & infections · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Azza S ZakariaMicrobiology and Immunology Department, Faculty of Pharmacy, Alexandria University, Alexandria 21500, Egypt.ORCID 0000-0003-3772-1381
Eva A EdwardMicrobiology and Immunology Department, Faculty of Pharmacy, Alexandria University, Alexandria 21500, Egypt.ORCID 0000-0001-9426-5074
Nelly M MohamedMicrobiology and Immunology Department, Faculty of Pharmacy, Alexandria University, Alexandria 21500, Egypt.ORCID 0000-0001-9073-5032
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reintroduction of colistin, a last-resort antibiotic for multidrug-resistant pathogens, resulted in the global spread of plasmid-mediated mobile colistin resistance (

Indexed as

colistin resistanceEgyptIncHI2 plasmidmcr-1multidrug resistant uropathogenic E. coliwhole genome sequencing

Identifiers

PMID33920265
PMCPMC8069611
OpenAlexW3154015165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.